Pfizer Inc. Recalls Pain Drug Acquired in King Pharmaceuticals®, Inc. Deal

(Reuters) - Just weeks after completing its $3.6 billion purchase of King Pharmaceuticals, Pfizer Inc has recalled an opioid painkiller obtained in the deal and said it could remain unavailable for many months because of formulation problems.